Congress ticker disclosure profile

As of July 18 at 5:02 AM EDT

Public STOCK Act rows mentioning

THO

A factual page for public Congressional disclosures that reference THO. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.

90d rows

0

Feed lifetime

16

Member filers

4

Disclosed ranges

$97K

Latest source-stamped receipts

Latest trade Jul 14, 2023

DateMemberActionAmountFiledReceipt
Jul 14, 2023Daniel GoldmanSell$1,001 to $15,000Aug 13, 2023Open card
Apr 10, 2023Daniel GoldmanSell$1,001 to $15,000May 19, 2023Open card
Dec 7, 2018Thomas MacarthurSellReceipt pending ingestionJan 11, 2019Receipt pending ingestion
Oct 24, 2018Thomas MacarthurBuyReceipt pending ingestionDec 6, 2018Receipt pending ingestion
Sep 20, 2018Thomas J. RooneySellReceipt pending ingestionDate not disclosedReceipt pending ingestion
Sep 20, 2018Thomas J. RooneySell$15,001 to $50,000Date not disclosedOpen card
Aug 6, 2018Gary PalmerBuyReceipt pending ingestionSep 29, 2018Receipt pending ingestion
Jul 12, 2018Gary PalmerBuyReceipt pending ingestionSep 29, 2018Receipt pending ingestion
Jul 5, 2018Gary PalmerBuyReceipt pending ingestionSep 29, 2018Receipt pending ingestion
Jun 8, 2018Thomas MacarthurBuyReceipt pending ingestionJul 10, 2018Receipt pending ingestion
May 29, 2018Thomas J. RooneyBuyReceipt pending ingestionDate not disclosedReceipt pending ingestion
May 29, 2018Thomas J. RooneyBuy$1,001 to $15,000Date not disclosedOpen card
Mar 28, 2018Thomas J. RooneyBuyReceipt pending ingestionDate not disclosedReceipt pending ingestion
Mar 28, 2018Thomas J. RooneyBuy$1,001 to $15,000Date not disclosedOpen card
Feb 27, 2018Thomas J. RooneyBuyReceipt pending ingestionDate not disclosedReceipt pending ingestion
Feb 27, 2018Thomas J. RooneyBuy$15,001 to $50,000Date not disclosedOpen card

Source creed

This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 6 of 16 filed rows include disclosed amount ranges (38%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.